leisure time -WSS

leisure time

author：hotspot 2025-10-01 05:47:04 Page View：172

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Elizabeth Holmes on track for early release from her 11
Next article： Virginia high school admissions case could be legal follow

comprehensive

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

HCA discloses massive data breach affecting 11 million patients

AdobeHCAHealthcarerevealedMondaythatit’sexperiencedwhatislikelythelargestdatabreacheverreportedbyahe

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Charles Manson follower Leslie Van Houten released from prison after 53 years

1:54LeslieVanHoutenattendsherparolehearingattheCaliforniaInstitutionforWomenSept.6,2017inCorona,Cali

leisure time

explore

comprehensive

Charles Manson follower Leslie Van Houten released from prison after 53 years